Quantinno Capital Management LP Argenx Se Transaction History
Quantinno Capital Management LP
- $4.53 Billion
- Q1 2024
A detailed history of Quantinno Capital Management LP transactions in Argenx Se stock. As of the latest transaction made, Quantinno Capital Management LP holds 1,351 shares of ARGX stock, worth $638,847. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,351
Previous 1,035
30.53%
Holding current value
$638,847
Previous $393,000
35.11%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
356Shares Held
31.3MCall Options Held
212KPut Options Held
210K-
Price T Rowe Associates Inc Baltimore, MD5.5MShares$2.6 Billion0.27% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.19MShares$1.51 Billion1.93% of portfolio
-
Janus Henderson Group PLC London, X02.22MShares$1.05 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.12MShares$1 Billion0.51% of portfolio
-
Capital World Investors Los Angeles, CA1.86MShares$882 Million0.13% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $26.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...